These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2802565

  • 1. Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens.
    Hanson LH, Stevens DA.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1391-2. PubMed ID: 2802565
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species.
    Zhanel GG, Karlowsky JA, Harding GA, Balko TV, Zelenitsky SA, Friesen M, Kabani A, Turik M, Hoban DJ.
    Antimicrob Agents Chemother; 1997 Apr; 41(4):863-5. PubMed ID: 9087508
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F, Lambert C, Van der Auwera P.
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Susceptibility of Candida species to cilofungin (LY-121019).
    Torres-Rodriguez JM, Carrillo-Muñoz A, Gallach-Bau C, Madrenys N.
    Mycoses; 1989 Jun; 32(6):316-8. PubMed ID: 2779613
    [Abstract] [Full Text] [Related]

  • 6. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
    Smith KR, Lank KM, Dismukes WE, Cobbs CG.
    Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections.
    Rennie RP, Hellman L.
    Mycoses; 1989 Mar; 32(3):145-50. PubMed ID: 2733726
    [Abstract] [Full Text] [Related]

  • 11. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.
    Espinel-Ingroff A, Kerkering TM, Goldson PR, Shadomy S.
    J Clin Microbiol; 1991 Jun; 29(6):1089-94. PubMed ID: 1864923
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of in vitro antifungal activity of LY121019.
    Hobbs M, Perfect J, Durack D.
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):77-80. PubMed ID: 3132385
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils.
    Meshulam T, Levitz SM, Diamond RD, Sugar AM.
    J Antimicrob Chemother; 1989 Nov; 24(5):741-5. PubMed ID: 2689424
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species.
    Huang A, Edwards F, Bernard EM, Armstrong D, Schmitt HJ.
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):697-9. PubMed ID: 2226501
    [Abstract] [Full Text] [Related]

  • 18. [In vitro antifungal activity of anidulafungin].
    Quindós G, Eraso E.
    Rev Iberoam Micol; 2008 Jun; 25(2):83-91. PubMed ID: 18473502
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activity of cilofungin (LY121019) against Candida species in vitro.
    Odds FC.
    J Antimicrob Chemother; 1988 Dec; 22(6):891-7. PubMed ID: 3243737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.